Atrial Fibrosis in Obstructive Sleep Apnea Patients: A Pilot Study
NCT: NCT04814420 · RECRUITING
Brief Summary
The investigators hypothesize that Obstructive Sleep Apnea (OSA) is an independent risk factor for atrial fibrosis development. The investigators aim to prove the presence of atrial fibrosis on Delayed Enhancement Magnetic Resonance Imaging (DE-MRI) in OSA patients without atrial fibrillation (AF).
Frequently Asked Questions
What is Atrial Fibrosis in Obstructive Sleep Apnea Patients: A Pilot Study?
Atrial Fibrosis in Obstructive Sleep Apnea Patients: A Pilot Study is a clinical trial registered under NCT04814420. Current status: RECRUITING.
What is the status of NCT04814420?
The current status of NCT04814420 (Atrial Fibrosis in Obstructive Sleep Apnea Patients: A Pilot Study) is: RECRUITING.
When did Atrial Fibrosis in Obstructive Sleep Apnea Patients: A Pilot Study start?
Atrial Fibrosis in Obstructive Sleep Apnea Patients: A Pilot Study started on 2021-07-12.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.